Ranbaxy Laboratories

Rediff.com » News » Ranbaxy Laboratories

News for Ranbaxy Laboratories

Business

Malaysia's IHH plans India expansion after Fortis open offer

After completion of its mandatory tender offer in Fortis Healthcare and Fortis Malar Hospitals, Malaysian health care giant IHH Healthcare is aiming to add 2,000 beds in a bid to double down on......

Ranbaxy resumes supply of Atorvastatin tablets in US

Drug major Ranbaxy Laboratories said on Monday it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market."Ranbaxy Pharmaceuticals Inc, the US......

Watson sends patent challenge notice to Ranbaxy for acne drug

Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica. The drug is licensed to Ranbaxy Laboratories......

Ranbaxy president & CFO Omesh Sethi quits

Drug maker Ranbaxy Laboratories said on Thursday its president and chief financial officer Omesh Sethi has resigned from the services of the company."Omesh Sethi, president & chief financial......

Ranbaxy returns to profit in Q2 on robust volumes

Drug firm Ranbaxy Laboratories on Monday reported a consolidated net profit of Rs 477.75 crore (Rs 4.77 billion)for the quarter ended September 30, 2014 on account of robust sales. The company had......

Ranbaxy Laboratories

News for Ranbaxy Laboratories

Malaysia's IHH plans India expansion after Fortis open offer

Ranbaxy resumes supply of Atorvastatin tablets in US

Watson sends patent challenge notice to Ranbaxy for acne drug

Ranbaxy president & CFO Omesh Sethi quits

Ranbaxy returns to profit in Q2 on robust volumes

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS